ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

TELA TELA Bio Inc

4.63
0.00 (0.00%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
TELA Bio Inc TELA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 4.63 09:00:00
개장가 저가 고가 종가 전일 종가
4.67 4.55 4.71 4.63 4.63
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202420:00GLOBETELA Bio to Announce First Quarter 2024 Financial Results
15/04/202420:00GLOBETELA Bio Announces U.S. Commercial Launch of..
08/04/202420:00GLOBETELA Bio Welcomes Acclaimed Surgeon as Vice President of..
22/03/202405:05GLOBETELA Bio Achieves Record Fourth Quarter and Full Year 2023..
21/03/202420:00GLOBETELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the..
20/03/202420:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
29/02/202421:00GLOBETELA Bio to Announce Fourth Quarter and Full Year 2023..
28/02/202406:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202406:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
17/02/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:05EDGAR2Form 3/A - Initial statement of beneficial ownership of..
15/02/202407:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202420:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/01/202406:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
16/12/202306:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
08/12/202306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202321:00GLOBETELA Bio to Take Part in Connecting the Dots
16/11/202321:00GLOBETELA Bio to Participate in Piper Sandler’s 35th Annual..
15/11/202310:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202306:44EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/11/202306:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
10/11/202306:05GLOBETELA Bio Reports Third Quarter 2023 Financial Results
26/10/202320:00GLOBETELA Bio to Announce Third Quarter 2023 Financial Results
21/10/202305:06EDGAR2Form 8-K - Current report
07/10/202300:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/09/202305:05EDGAR2Form 8-K - Current report
19/09/202305:05GLOBETELA Bio to Participate in the Gilmartin Group Emerging..
16/08/202320:15EDGAR2Form 8-K - Current report
16/08/202320:00GLOBETELA Bio Announces U.S. Commercial Launch of OviTex® PRS..
11/08/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:05EDGAR2Form 8-K - Current report
10/08/202305:03GLOBETELA Bio Reports Second Quarter 2023 Financial Results
05/08/202305:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/08/202305:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/08/202305:02GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
26/07/202320:00GLOBETELA Bio to Announce Second Quarter 2023 Financial Results..
15/06/202320:00GLOBENew Survey Finds Strong Consumer Preference for More Natural..
25/05/202320:00GLOBETELA Bio to Participate in the Jefferies Global Healthcare..
19/05/202320:00GLOBETELA Bio Invests in Surgeon Training and Education with..
12/05/202305:02GLOBETELA Bio Reports First Quarter 2023 Financial Results
09/05/202320:00GLOBETELA Bio Supports Diversity and Inclusion at International..
09/05/202305:30GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..

최근 히스토리

Delayed Upgrade Clock